查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1758068

全球心臟修復系统市场

Cardiac Restoration Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 270 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球心臟修復系统市场规模将达到 7.599 亿美元

全球心臟修復系统市场规模预计在2024年为6.007亿美元，到2030年将达到7.599亿美元，在2024-2030年的分析期间内，复合年增长率为4.0%。二尖瓣修復系统是本报告分析的细分市场之一，预计其复合年增长率为3.2%，到分析期结束时将达到4.586亿美元。左心室修復系统细分市场在分析期间的复合年增长率预计为5.3%。

美国市场规模估计为 1.637 亿美元，中国市场预计复合年增长率为 7.2%

美国心臟修復系统市场规模预计2024年达到1.637亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到1.531亿美元，在2024-2030年的分析期间内，复合年增长率为7.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，复合年增长率分别为1.7%和3.1%。在欧洲，德国的复合年增长率预计为2.3%。

全球心臟修復系统市场－主要趋势与驱动因素摘要

为什么心臟修復系统会成为晚期心臟衰竭治疗的基石？

心臟修復系统作为一种创新的延长生命解决方案，已获得广泛关注，适用于心臟衰竭和相关结构性心臟疾病的患者。这些系统旨在重塑、支撑和强化衰竭的心臟，尤其是左心室，使其恢復正常形状、改善功能并减轻郁血性的相关症状。心血管疾病仍然是全球头号死因，数百万人患有慢性心臟衰竭衰竭，迫切需要药物治疗和侵入性移植手术的替代方案。心臟修復在药物治疗和更积极的治疗方法（例如辅助人工心臟(VAD) 和心臟移植）之间架起了一座桥樑，这对于不适合接受此类治疗的患者尤其有价值。心外膜植入、心室重塑装置和可注射生物支架等系统可以在不显着损害心臟自然解剖结构的情况下恢復心臟的机械效率。随着心臟病发作后存活率的提高，越来越多的患者将承受心臟损伤的长期影响，这增加了对修復方法的需求。此外，新兴国家早期诊断的改进、对心臟病认识的提高以及心臟护理的改善，正在扩大可从这些治疗方法中受益的患者群体。心臟修復系统现在被认为是一种可行的长期解决方案，它不仅可以改善心抟出量，还可以提高患者的生活品质和功能独立性，最终降低医疗保健利用率和住院费用。

科技进步如何提高心臟修復设备的性能和适应性？

技术创新在扩展心臟修復系统的功能和精确度方面发挥了变革性作用，使其更安全、更有效，并能适应更广泛的患者解剖结构和疾病进展。材料科学的发展促进了生物相容性和柔性植入材料的开发，这些材料可以模拟心臟组织动态，降低併发症风险并促进与心肌的整合。小型化以及经导管系统和影像引导导航等输送工具的引入，使得这些设备能够以微创方式部署，显着减少手术创伤和恢復时间。一些最新系统使用 3D 列印和患者特定建模，根据患者独特的心室解剖结构量身定制植入，从而改善治疗效果。此外，已经开发出生物可吸收支架和可注射水凝胶，它们可以促进组织再生，同时逐渐降解，无需移除即可留下修復的心臟环境。与即时成像和术中监测技术的结合，可确保设备的精确放置和最佳化功能。此外，整合到修復系统中的智慧材料和生物感测器能够提供设备性能、压力梯度和心臟功能的早期回馈，开启数据驱动的个人化治疗时代。这些创新不仅增强了心臟修復系统的治疗潜力，也使其适用范围扩大到更广泛的心臟衰竭心臟衰竭，包括早期结构性恶化和合併症患者。随着技术的不断发展，心臟修復程序正成为现代心臟衰竭管理的标准组成部分。

哪些医疗保健趋势和临床实践正在影响心臟修復系统的需求？

医疗保健服务、临床指南和患者期望的变化正在深刻影响全球循环系统网路中心臟修復系统的实施。随着个人化和精准医疗日益受到重视，临床医生越来越多地寻求治疗方法解决心臟衰竭潜在机械原因而非仅仅控制症状的治疗方法。心臟修復系统透过针对心室扩张、室壁变薄和收缩力减弱来满足这一需求，这些都是收缩性心臟衰竭患者心臟心臟衰竭下降的主要驱动因素。由循环系统、外科医生和电生理学家组成的多学科心臟护理团队的兴起也促进了对这些系统进行更广泛的评估并将其纳入标准治疗方案。此外，随着心臟衰竭逐渐成为一种慢性、可控制的疾病，而非立即被诊断为终末期疾病，心臟修復等长期解决方案对于维持患者独立生活、减少对反覆住院和复杂器械治疗的依赖至关重要。保险报销框架正在不断发展，以认识到此类系统的成本节约潜力，尤其是在减少再入院以及延缓或避免心臟移植方面。在教育水平的提高、同侪倡导以及将患者与新的治疗方案联繫起来的数位健康平台的推动下，患者对新疗法的认知和接受意愿也在不断提高。支持心臟修復设备安全性和有效性的临床试验数据越来越可靠，这鼓励医生在治疗过程中儘早采用这些方法。随着医疗保健模式转向更积极主动、以结果为导向的模式，对诸如提供结构矫正和功能恢復的心臟修復系统等治疗性介入的需求将持续增长。

是什么推动了全球心臟修復系统市场的成长？

心臟修復系统市场的成长受到多种因素的共同推动，包括心臟衰竭盛行率的上升、技术进步、良好的临床疗效以及对价值导向医疗的策略性推动。在全球范围内，人口老化和心肌梗塞后存活率的上升导致患有慢性心臟功能障碍的患者数量不断增加。不断增长的患者群体推动了对中阶干预措施的需求，这些措施能够切实改善心臟功能，且无需承担全外科置换术或机械循环支持的风险和局限性。从技术角度来看，影像处理、材料科学和设备小型化的创新使心臟修復系统更易于取得和部署，使其在学术和社区医疗保健环境中得到更广泛的应用。良好的临床试验数据和真实世界证据表明射血分数、运动能力和症状缓解均有所改善，进一步检验了这些设备的市场潜力。此外，监管途径也日趋简化，一些设备已获得 CE 标誌核准或 FDA 等机构的快速通道认证，从而加快了其市场准入和广泛应用。从经济角度来看，医疗保健系统越来越倾向于减少医院再入院率、积极管理慢性病并降低总护理成本。医疗设备公司、学术机构和医院网路之间的策略合作也正在刺激奖励和市场渗透。这些因素共同构成了持续成长的坚实基础，使心臟修復系统成为不断发展的心臟衰竭治疗领域的关键创新。

部分

产品（二尖瓣修復系统、左心室修復系统）；最终用途（医院最终用途、门诊手术中心最终用途、其他最终用途）

受访公司范例

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Cardiac Dimensions, Inc.
  • Cardiovascular Systems, Inc.
  • Corindus Vascular Robotics
  • Edwards Lifesciences
  • Endotronix, Inc.
  • Fresenius Medical Care
  • LivaNova PLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Penumbra, Inc.
  • Shockwave Medical, Inc.
  • Siemens Healthineers
  • Spectranetics Corporation
  • Terumo Corporation
  • Zoll Medical Corporation

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 并未遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自全球领域专家的精选内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP36474

Global Cardiac Restoration Systems Market to Reach US$759.9 Million by 2030

The global market for Cardiac Restoration Systems estimated at US$600.7 Million in the year 2024, is expected to reach US$759.9 Million by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Mitral Valve Restoration Systems, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$458.6 Million by the end of the analysis period. Growth in the Left Ventricular Restoration Systems segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$163.7 Million While China is Forecast to Grow at 7.2% CAGR

The Cardiac Restoration Systems market in the U.S. is estimated at US$163.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$153.1 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Cardiac Restoration Systems Market - Key Trends & Drivers Summarized

Why Are Cardiac Restoration Systems Emerging as a Cornerstone in Advanced Heart Failure Treatment?

Cardiac restoration systems are gaining significant traction as innovative, life-extending solutions for patients suffering from heart failure and related structural heart conditions. These systems are designed to reshape, support, or reinforce the failing heart-particularly the left ventricle-to restore normal geometry, improve function, and reduce symptoms associated with congestive heart failure. As cardiovascular disease remains the leading cause of death globally, with millions affected by chronic heart failure, there is an urgent demand for therapeutic alternatives beyond pharmacological treatment and invasive transplant procedures. Cardiac restoration offers a bridge between medical management and more aggressive interventions like ventricular assist devices (VADs) or heart transplantation, making it particularly valuable for patients who are not suitable candidates for such procedures. Systems such as epicardial implants, ventricular remodeling devices, and injectable bio-scaffolds work to restore the mechanical efficiency of the heart without significantly compromising its natural anatomy. As survival rates post-heart attack improve, more patients are living with the long-term consequences of cardiac damage, driving demand for restorative approaches. Furthermore, improvements in early diagnosis, increased awareness of heart disease, and better access to cardiac care in emerging economies are broadening the patient pool eligible for these interventions. Cardiac restoration systems are now viewed as a viable long-term solution that not only improves cardiac output but also enhances patients' quality of life and functional independence, ultimately reducing healthcare utilization and hospitalization costs.

How Are Technological Innovations Enhancing the Performance and Adaptability of Cardiac Restoration Devices?

Technological innovation is playing a transformative role in expanding the capabilities and precision of cardiac restoration systems, making them safer, more effective, and increasingly adaptable to a wider range of patient anatomies and disease progressions. Advances in material science have led to the development of biocompatible and flexible implant materials that mimic cardiac tissue mechanics, reducing the risk of complications and enhancing integration with the myocardium. Miniaturization and the incorporation of delivery tools like transcatheter systems and image-guided navigation have enabled less invasive deployment of these devices, significantly reducing surgical trauma and recovery times. Some of the latest systems use 3D printing and patient-specific modeling to customize implants based on a patient’s unique ventricular structure, improving therapeutic outcomes. Furthermore, bioresorbable scaffolds and injectable hydrogels are being developed to promote tissue regeneration while gradually degrading, leaving behind a restored cardiac environment without the need for removal. Integration with real-time imaging and intraoperative monitoring technologies ensures precise device placement and function optimization. Additionally, smart materials and biosensors embedded in restoration systems are providing early feedback on device performance, pressure gradients, and cardiac function, ushering in the era of data-driven, personalized therapy. These innovations are not only enhancing the therapeutic potential of cardiac restoration systems but are also expanding their applicability across a broader spectrum of heart failure patients, including those with early-stage structural deterioration or coexisting comorbidities. As technology continues to evolve, cardiac restoration is poised to become a standard component of modern heart failure management.

What Healthcare Trends and Clinical Practices Are Shaping the Demand for Cardiac Restoration Systems?

Shifts in healthcare delivery, clinical guidelines, and patient expectations are significantly influencing the adoption of cardiac restoration systems across global cardiology networks. With the growing emphasis on personalized and precision medicine, clinicians are increasingly looking for treatment modalities that address the root mechanical causes of heart failure rather than simply managing symptoms. Cardiac restoration systems fulfill this demand by targeting ventricular dilation, wall thinning, and impaired contractility, which are key contributors to declining heart function in systolic heart failure. The rise in multidisciplinary heart teams, composed of cardiologists, surgeons, and electrophysiologists, is also facilitating broader evaluation and integration of these systems into standard care protocols. Furthermore, as heart failure becomes a chronic, manageable condition rather than an immediate terminal diagnosis, long-term solutions like cardiac restoration are gaining importance for maintaining patient independence and reducing reliance on repeated hospitalizations or complex device therapy. Reimbursement frameworks are evolving to recognize the cost-saving potential of these systems, particularly in reducing readmissions and delaying or avoiding the need for heart transplants. Patient awareness and willingness to pursue novel therapies have also increased, driven by better education, peer advocacy, and digital health platforms that connect patients to emerging treatment options. Clinical trial data supporting the safety and efficacy of cardiac restoration devices is becoming more robust, encouraging physicians to adopt these approaches earlier in the treatment pathway. As healthcare moves toward more proactive, outcome-oriented models, the demand for therapeutic interventions like cardiac restoration systems that offer structural correction and functional recovery will continue to accelerate.

What’s Driving the Growth of the Global Cardiac Restoration Systems Market?

The growth in the cardiac restoration systems market is driven by several intersecting factors, including the rising prevalence of heart failure, technological advancements, favorable clinical outcomes, and the strategic push toward value-based care. Globally, aging populations and increased survival rates following myocardial infarction are contributing to a larger patient base living with chronic cardiac dysfunction. This expanding population fuels the demand for mid-range interventions that offer tangible improvements in heart function without the risks or limitations of full surgical replacement or mechanical circulatory support. From a technological perspective, innovations in imaging, material science, and device miniaturization are making cardiac restoration systems more accessible and easier to deploy, allowing for broader adoption in both academic and community healthcare settings. Positive clinical trial data and real-world evidence demonstrating improvements in ejection fraction, exercise capacity, and symptom relief are further validating the market potential of these devices. Additionally, regulatory pathways are becoming more streamlined, with several devices gaining CE Mark approval or fast-track designations from agencies like the FDA, facilitating quicker market entry and adoption. On the financial front, healthcare systems are increasingly incentivized to reduce hospital readmissions, manage chronic conditions proactively, and lower the total cost of care-goals that align well with the function and promise of cardiac restoration therapy. Strategic collaborations between medical device companies, academic institutions, and hospital networks are also fueling innovation and market penetration. Altogether, these dynamics are creating a robust foundation for sustained growth, positioning cardiac restoration systems as a critical innovation in the evolving landscape of heart failure treatment.

SCOPE OF STUDY:

The report analyzes the Cardiac Restoration Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Mitral Valve Restoration Systems, Left Ventricular Restoration Systems); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Cardiac Dimensions, Inc.
  • Cardiovascular Systems, Inc.
  • Corindus Vascular Robotics
  • Edwards Lifesciences
  • Endotronix, Inc.
  • Fresenius Medical Care
  • LivaNova PLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Penumbra, Inc.
  • Shockwave Medical, Inc.
  • Siemens Healthineers
  • Spectranetics Corporation
  • Terumo Corporation
  • Zoll Medical Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Cardiac Restoration Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Heart Failure Throws the Spotlight on Cardiac Restoration as a Transformative Therapy Option
    • Limitations of Conventional Treatments Accelerate Demand for Minimally Invasive Cardiac Restoration Systems
    • Expansion of Structural Heart Disease Programs Strengthens the Business Case for Ventricular Restoration Technologies
    • Aging Population and Higher Heart Disease Risk Profiles Sustain Long-Term Need for Cardiac Repair Solutions
    • Breakthroughs in Device-Based Therapies Propel Growth in Left Ventricular Restoration System Adoption
    • Patient Preference for Minimally Invasive Options Drives Adoption of Transcatheter-Based Restoration Platforms
    • Increased Clinical Trials and Real-World Data Enhance Confidence in Efficacy of Cardiac Restoration Devices
    • Hospital Focus on Readmission Reduction and Functional Improvement Supports Integration into Heart Failure Care Pathways
    • Rising Use of Cardiac MRI and Advanced Imaging Fuels Personalized Planning for Restoration Procedures
    • Surge in Advanced Heart Failure Referrals Spurs Market Demand for Bridge-to-Recovery Solutions
    • Integration with Digital Health Tools and Remote Monitoring Strengthens Post-Procedure Outcome Tracking
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Restoration Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiac Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Mitral Valve Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Mitral Valve Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Mitral Valve Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Left Ventricular Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Left Ventricular Restoration Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Left Ventricular Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Cardiac Restoration Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Cardiac Restoration Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Cardiac Restoration Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Cardiac Restoration Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Cardiac Restoration Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Cardiac Restoration Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Cardiac Restoration Systems by Product - Mitral Valve Restoration Systems and Left Ventricular Restoration Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Cardiac Restoration Systems by Product - Percentage Breakdown of Value Sales for Mitral Valve Restoration Systems and Left Ventricular Restoration Systems for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Cardiac Restoration Systems by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Cardiac Restoration Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION